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Abstract
            We report two cases of patients of cardiac resynchronization therapy (CRT) whose 
ECGs, during follow up, showed different paced QRS morphology as compared to those of 
immediate post-device implantation. Parameters of leads, including sensitivity and capture 
thresholds, were unchanged. There was no lead dislodgement confirmed on fluoroscopy. The 
ECGs obtained in device off mode showed different intrinsic QRS morphology as compared to 
those of pre-implant morphology. These changes were attributable to electrolyte imbalance in 
one patient and progressive intraventricular  conduction defect in the other. These cases 
demonstrate that intrinsic myocardial conduction pattern influences paced QRS morphology. 
Irreversible change in paced QRS morphology may indicate poor prognosis.
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Introduction
            Change in the paced QRS morphology in patients with CRT devices can be due to loss of 
capture, dislodgement of ventricular pacing leads, change in the pacing timing of ventricular 
leads (V-V delay) as well as electrolyte and acid base imbalance without significant change in 
threshold1,2. Influence of change in intrinsic myocardial conduction pattern on paced QRS 
morphology has not been studied well so far.                                                               
            Here we present two case reports in which change in paced QRS morphology was 
attributable exclusively to change in the intrinsic myocardial conduction pattern without change 
in lead parameters or position. In one case the change in intramyocardial conduction pattern was 
due to electrolyte imbalance and in another it was due to progression of myocardial disease.
Case   1                                                                                                      
            A 66 years old diabetic male with ischaemic cardiomyopathy had undergone CRT for 
symptomatic congestive heart failure despite optimal medical  management.  His  baseline  ECG 
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(Figure 1a) showed sinus rhythm, complete RBBB with QRS duration of 130ms. The post-
implant ECG (Figure 1b) showed sinus rhythm and paced QRS duration of 100 ms with North 
West QRS axis. Left ventricle was set to be paced 40 ms earlier than RV, to achieve optimal 
synchronization based on echocardiographic parameters.
Figure 1a: Baseline ECG with wide QRS (RBBB)
Figure 1b: Post implant ECG 
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            The patient was doing well for 18 months following CRT, then presented to us with 
altered sensorium of 6 hours duration. There was no history of dyspnea, angina or palpitation. 
His ECG (Figure 2a) showed atrial paced and biventricular paced rhythm. However the paced 
QRS morphology was significantly different as compared to previous post-implant ECGs. The 
QRS duration (210 ms) was wider by 110 ms. Interrogation of the device revealed no significant 
changes in lead parameters and ventricular capture thresholds. Fluoroscopy revealed no lead 
dislodgement.   ECG (Figure 2b) obtained when the device was temporarily switched off 
showed wider QRS complexes (150 ms) as compared to pre-implant ECG with prolonged PR 
interval (260 ms) and left axis deviation.  
Figure 2a: ECG showing widening of paced QRS due to hyperkalemia
Figure 2b: ECG with device in switched off mode
            His biochemical parameters revealed hyperglycemia (random blood sugar 400mg/dl) and 
hyperkalemia (serum potassium 6.5 mEq/L). Ketones were present in blood and urine. Renal 
parameters were mildly deranged (urea 50 mg/dl, creatinine 1.6 mg/dl). He was treated for 
metabolic encephalopathy with diabetic ketoacidosis. Over a period of 36 hours   when 
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biochemical and electrolyte parameters returned to normal, patient became asymptomatic, with 
clear sensorium. The morphology of paced QRS complex on surface ECG as well as that of 
intrinsic QRS became identical to that of immediate post-implant ECG.                        
Case   2                                                                                  
            A 38 years lady with idiopathic dilated cardiomyopathy underwent CRT for refractory 
heart failure despite optimal medical management. Pre-implant ECG showed (Figure 3a) - sinus 
rhythm, prolonged PR interval (220ms), complete LBBB, QRS duration of 120ms and left axis. 
Post-implant ECG (Figure 3b), after optimizing her A-V & V-V delays showed sinus rhythm, 
QRS duration of 100 ms and left axis. Left ventricle was set to be paced 40 ms earlier than RV. 
She was doing well for 15 months after which she started becoming breathless. Breathlessness 
gradually worsened over a period of one month and she presented to us with complaints of 
orthopnea and reduced urine output. On admission patient was in pulmonary oedema and her 
ECG (Figure 4a) showed atrial sensed, biventricular paced rhythm. However the paced QRS 
morphology was significantly different and wider as compared to previous post-implant ECGs. 
The QRS complexes were of RBBB morphology with superior axis. The QRS duration (180 ms) 
was   wider   by   60   milliseconds.   Lead(s)   dislodgement   or   capture   failure   was   suspected.
  
Figure 3a: Baseline ECG with wide QRS (lBBB) 
Figure 3b: Post implant ECG
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 8 (3): 211-217 (2008)Rajendra Deshmukh, K Latchumanadhas, S Mullasari Ajit, Ulhas M. Pandurangi,    215 
“Influence of Intrinsic Myocardial Conduction on Paced QRS Morphology During Cardiac 
Resynchronization Therapy Follow up”
Figure 4a: ECG showing widening of paced QRS due to progressive disease
Figure 4b: ECG with device in switched off mode
            However device interrogation and fluoroscopy ruled out lead and device related issues. 
The ECG (Figure 4b) obtained when the device was temporarily switched off showed wider 
QRS complexes (168 ms) with prolonged PR interval (200 ms) and atrial enlargement as 
compared to pre-implant ECG. Echocardiography revealed severe biventricular dysfunction with 
increase in size of chambers as compared to one-year follow up. She had mildly elevated renal 
parameters (urea 47 mg/dl, creatinine 1.4 mg/dl) with normal electrolytes. She was stabilized 
with diuretics and additional inotropic support. After 10 days, at the time of discharge, the QRS 
morphology (on and off pacing) continued to be wider. Patient ultimately succumbed to 
progressive pump failure 2 months later.
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Discussion  
            In addition to mechanical synchrony, electrical synchrony is also achieved in majority of 
patients with CRT3,4. Electrical synchrony manifests on ECG as reduction in the width of 
QRS5,6. The changes in the paced QRS morphology can be due to loss of capture, lead 
dislodgement,   electrolyte   imbalance   and   drugs   like   amiodarone1,2.   The   changes   in   the 
morphology of QRS can also be due to progression of intrinsic disease involving myocardium 
and conduction system7. Hyperkalemia in CHF is usually a consequence of associated renal 
dysfunction or drug therapy (angiotensin converting enzyme inhibitors, angiotensin receptor 
blockers, potassium sparing diuretics etc.) or both. Hyperkalemia causes changes in the paced 
QRS morphology by the following mechanisms. An increase in the concentration of extra 
cellular potassium lowers the resting membrane potential, leading to a reduction of the upstroke 
velocity, amplitude, and duration of the action potential. This effect has been recorded in atrial, 
ventricular, and Purkinje fibers and is manifest on the ECG by changes in the amplitude and 
duration of the P wave and the QRS complex8. A mild to moderate hyperkalemia causes increase 
in myocardial excitability but further increase leads to impaired myocardial responsiveness to 
pacing stimulus9. It may produce various degrees of exit blocks10,11. In our first patient renal 
impairment and angiotensin converting enzyme inhibitor were considered to be the culprits 
responsible for hyperkalemia. Measures initiated to normalize potassium levels, promptly 
restored the paced QRS morphology as well as intrinsic QRS morphology.                  
            Progression of myocardial disease per se has been shown to progressively widen the 
QRS complex in idiopathic dilated cardiomyopathy12,13. Increasing size of cardiac chambers, and 
concomitant involvement of conduction system by the disease process has been implicated for 
the change in QRS morphology14,15. In our second case the change in intrinsic QRS morphology 
was due to progression of underlying disease. The fulminant course leading to death in this 
patient suggests that change in the paced QRS morphology in the absence of known causes is a 
sign   of   poor   prognosis.                                                                      
               To the best of our knowledge there has been no published case reports describing 
hyperkalemia and progressive myocardial disease as reasons for changes in the paced QRS 
morphology   in   CRT   patients.                                                                      
Conclusion
            Irreversible change in the paced QRS morphology during CRT follow up can be due to 
gradual progression of underlying cardiomyopathy. This phenomenon is indicative of poor 
prognosis. Reversible changes in the paced QRS morphology carry a benign prognosis.  These 
changes may be due to underlying electrolyte abnormality like hyperkalemia. 
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